Citations

Clear

382 citation(s) found for "Li, Man".

A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus
Chowdhary, Vaidehi , Dai, Chao , Tilahun, Ashenafi Y. , Hanson, Julie A., Smart, Michele, Grande, Joseph P. , Rajagopalan, Govindarajan , Fu, Shu Man , David, Chella S., Chowdhary, Vaidehi R, Smart, Michele K

Mayo Clinic

The Journal of Immunology | October 17, 2015 | Volume: 195 | Issue: 10 | Pages: 4660-4667

10.4049/jimmunol.1501073 | PMID 26475924 Get It

Abstract MHC, especially HLA-DR3 and HLA-DR2, is one of the most important genetic susceptibility regions for systemic lupus erythematosus. Human studies to understand the role of specific HLA alleles in disease pathogenesis have been hampered by the presence of strong linkage disequilibrium in this region. To overcome this, we produced transgenic mice expressing HLA-DR3 (DRβ1*0301) and devoid of endogenous class II (both I-A and I-E genes, AE0) on a lupus-prone NZM2328 background (NZM2328.DR3+AE0). Both NZM2328 and NZM2328.DR3+AE0 mice developed anti-dsDNA and glomerulonephritis, but anti-dsDNA titers were higher in the latter. Although kidney histological scores were similar in NZM2328 and NZM2328.DR3+AE0 mice (7.2 ± 4.3 and 8.6 ± 5.7, respectively, p = 0.48), the onset of severe proteinuria occurred earlier in NZM2328.DR3+AE0 mice compared with NZM2328 mice (median, 5 and 9 mo respectively, p < 0.001). Periarterial lymphoid aggregates, classic wire loop lesions, and occasional crescents were seen only in kidneys from NZM2328.DR3+AE0 mice. Interestingly, NZM2328.DR3+AE0 mice, but not NZM2328 mice, spontaneously developed anti-Smith (Sm) Abs. The anti-Sm Abs were seen in NZM2328.DR3+AE0 mice that were completely devoid of endogenous class II (AE-/-) but not in mice homozygous (AE+/+) or heterozygous (AE+/−) for endogenous MHC class II. It appears that only HLA-DR3 molecules can preferentially select SmD-reactive CD4+ T cells for generation of the spontaneous anti-Sm immune response. Thus, our mouse model unravels a critical role for HLA-DR3 in generating an autoimmune response to SmD and lupus nephritis in the NZM2328 background.
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Spratt, Daniel E. , Doran, Michael G. , Lee, Man Xia, Shah, Neel , Wongvipat, John, Carnazza, Kathryn E., Klee, George G., Polkinghorn, William R., Tindall, Donald J., Lewis, Jason S. , Davis, Brian J. , Evans, Michael J. , Lee, Man Xia, Sawyers, Charles L. , Spratt, Daniel E

Mayo Clinic

Cancer Research | October 2, 2015 | Volume: 75 | Issue: 22 | Pages: 4688-4696

10.1158/0008-5472.can-15-0892 | PMID 26432404 Get It

Abstract Clinical trials have established the benefit of androgen deprivation therapy (ADT) combined with radiotherapy in prostate cancer. ADT sensitizes prostate cancer to radiotherapy-induced death at least in part through inhibition of DNA repair machinery, but for unknown reasons, adjuvant ADT provides further survival benefits. Here, we show that androgen receptor (AR) expression and activity are durably upregulated following radiotherapy in multiple human prostate cancer models in vitro and in vivo. Moreover, the degree of AR upregulation correlates with survival in vitro and time to tumor progression in animal models. We also provide evidence of AR pathway upregulation, measured by a rise in serum levels of AR-regulated hK2 protein, in nearly 20% of patients after radiotherapy. Furthermore, these men were three-fold more likely to experience subsequent biochemical failure. Collectively, these data demonstrate that radiotherapy can upregulate AR signaling after therapy to an extent that negatively affects disease progression and/or survival. Cancer Res; 75(22); 4688–96. ©2015 AACR.
Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data
Schiavon, Michele , Man, Chiara Dalla , Dube, Simmi , Slama, Michael , Kudva, Yogish C. , Peyser, Thomas A. , Basu, Ananda , Basu, Rita , Cobelli, Claudio , Dalla Man, Chiara , Schiavon, Michele

Mayo Clinic

Diabetes Technology & Therapeutics | August 27, 2015 | Volume: 17 | Issue: 11 | Pages: 825-831

10.1089/dia.2015.0119 | PMID 26313215 Get It

Background: Quantitative assessment of the dynamic relationship between plasma and interstitial fluid (ISF) glucose and the estimation of the plasma-to-ISF delay are of major importance to determine the accuracy of subcutaneous glucose sensors, an essential component of open- and closed-loop therapeutic systems for type 1 diabetes mellitus (T1DM). The goal of this work is to develop a model of plasma-to-ISF glucose kinetics from multitracer plasma and interstitium data, obtained by microdialysis, in healthy and T1DM subjects, under fasting conditions. Materials and Methods: A specific experimental design, combining administration of multiple tracers with the microdialysis technique, was used to simultaneously frequently collect plasma and ISF data. Linear time-invariant compartmental modeling was used to describe glucose kinetics from the tracer data because the system is in steady state. Results: A two-compartment model was shown accurate and was identified from both plasma and ISF data. An “equilibration time” between plasma and ISF of 9.1 and 11.0 min (median) in healthy and T1DM subjects, respectively, was calculated. Conclusions: We have demonstrated that, in steady-state condition, the glucose plasma-to-ISF kinetics can be modeled with a linear two-compartment model and that the “equilibration time” between the two compartments can be estimated with precision. Future studies will assess plasma-to-interstitium glucose kinetics during glucose and insulin perturbations in both healthy and T1DM subjects.
Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches
Mallad, Ashwini , Hinshaw, Ling , Man, Chiara Dalla , Basu, Rita , Lingineni, Ravi K., Carter, Rickey E. , Kudva, Yogish C. , Basu, Ananda , Lingineni, Ravi, Cobelli, Claudio , Dalla Man, Chiara , Carter, Rickey E

Mayo Clinic

Diabetes Technology & Therapeutics | June 29, 2015 | Volume: 17 | Issue: 8 | Pages: 587-595

10.1089/dia.2015.0011 | PMID 26121060 Get It

Background: Understanding the effect size, variability, and underlying physiology of the dawn phenomenon is important for next-generation closed-loop control algorithms for type 1 diabetes (T1D). Subjects and Methods: We used an iterative protocol design to study 16 subjects with T1D on individualized insulin pump therapy for two successive nights. Endogenous glucose production (EGP) rates at 3 a.m. and 7 a.m. were measured with [6,6- 2 H 2 ]glucose as a single tracer, infused from midnight to 7 a.m. in all subjects. To explore possibility of tracer recycling due to prolonged [6,6- 2 H 2 ]glucose infusion, which was highly probable after preplanned interim data analyses, we infused a second tracer, [6- 3 H]glucose, from 4 a.m. to 7 a.m. in the last seven subjects to measure EGP at 7 a.m. Results: Cortisol concentrations increased during both nights, but changes in glucagon and insulin concentration were inconsistent. Although the plasma glucose concentrations rose from midnight to 7 a.m. during both nights, EGP measured with [6,6- 2 H 2 ]glucose between 3 a.m. and 7 a.m. did not differ during Night 1 but fell in Night 2. However, EGP measured with [6- 3 H]glucose at 7 a.m. was higher than that measured with [6,6- 2 H 2 ]glucose during both nights, thereby suggesting tracer recycling probably underestimating EGP calculated at 7 a.m. with [6,6- 2 H 2 ]glucose. Likewise, EGP was higher at 7 a.m. with [6- 3 H]glucose than at 3 a.m. with [6,6- 2 H 2 ]glucose during both nights. Conclusions: The data demonstrate a consistent overnight rise in glucose concentrations through increased EGP, mediated likely by rising cortisol concentrations. The observations with the dual tracer approach imply significant tracer recycling leading to underestimation of EGP measured by longer-duration tracer infusion.
Mystery Case: A 21-year-old man with visual loss following marijuana use
Whitlock, Julia B., Robinson, Glen T., Whitlock, Joseph P., Dredla, Brynn K., Barrett, Kevin M.

Mayo Clinic

Neurology | May 25, 2015 | Volume: 84 | Issue: 21 | Pages: No page available

10.1212/wnl.0000000000001627 | PMID 26009564 Get It

Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model
Visentin, R. , Man, Chiara Dalla , Basu, Rita , Basu, Ananda , Rizza, Robert A., Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | May 19, 2015 | Volume: 309 | Issue: 2 | Pages: E161-E167

10.1152/ajpendo.00358.2014 | PMID 25991649 Get It

Recently, a model was proposed to assess hepatic insulin sensitivity during a meal, i.e., the ability of insulin to suppress glucose production (EGP), SIP. The model was developed on EGP data obtained from a triple-tracer meal and the tracer-to-tracee clamp technique and validated against the euglycemic hyperinsulinemic clamp. The aim of this study was to assess whether SIP can be obtained from plasma concentrations measured after a single-tracer meal by incorporating the above EGP model into the oral glucose minimal model by describing both glucose production and disposal (OMMPD). Triple-tracer meal data of two databases (20 healthy and 60 healthy and prediabetic subjects) were used. Virtually model-independent EGP estimates were calculated. OMMPD was identified on exogenous and endogenous glucose concentrations, providing indices of SIP, disposal insulin sensitivity (SID), and EGP. The model fitted the data well, and SIP and SID were estimated with precision in both databases (SIP = 5.48 ± 0.54 10−4 dl·kg−1·min−1 per μU/ml and SID = 9.93 ± 2.18 10−4 dl·kg−1·min−1 per μU/ml in healthy; SIP = 5.41 ± 3.55 10−4 dl·kg−1·min−1 per μU/ml and SID = 5.34 ± 6.17 10−4 dl·kg−1·min−1 per μU/ml, in healthy and prediabetic subjects). Estimated SIP and that derived from the triple-tracer EGP model were very similar on average. Moreover, the time course of EGP normalized to basal EGP (EGPb), and EGP/EGPb agreed with the results obtained using the triple-tracer method. In this study, we have demonstrated that SIP, SID, and EGP/EGPb time course can be estimated reliably from a single-tracer meal protocol in both healthy and prediabetic subjects.
A 53‐Year‐Old Man With Dysuria, Pyuria, and Genital Ulcers
Jimenez, Xavier , Psutka, Sarah P. , Stone, John H. , Carruthers, Mollie N. , Psutka, Sarah P

Mayo Clinic

Arthritis Care & Research | May 18, 2015 | Volume: 68 | Issue: 9 | Pages: 1371-1377

10.1002/acr.22617 | PMID 25989159 Get It

Development of Left Atrial Thrombus and Subsequent Cardioembolic Stroke in a 21-Year-Old Man With Ebstein Anomaly Who Previously Underwent Pulmonary Vein Isolation Ablation and Cox Maze III Procedure
Bois, John P. , Lin, Grace , Brady, Peter A. , Ammash, Naser M.

Mayo Clinic

Circulation | March 23, 2015 | Volume: 131 | Issue: 12 | Pages: 1110-1118

10.1161/circulationaha.115.015340 | PMID 25802257 Get It

Association Between Thyrotropin Levels and Insulin Sensitivity in Euthyroid Obese Adolescents
Javed, Asma , Balagopal, Prabhakaran , Piccinini, Francesca, Man, Chiara Dalla , Giesler, Paula D., Laugen, Jeanette M., Kumar, Seema , Vella, Adrian , Fischer, Philip R. , Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Thyroid® | March 17, 2015 | Volume: 25 | Issue: 5 | Pages: 478-484

10.1089/thy.2015.0005 | PMID 25777801 Get It

Background: Thyrotropin (TSH) levels display a positive association with body mass index (BMI), and the prevalence of isolated hyperthyrotropinemia is higher in obese adolescents compared to their normal weight controls. However, the metabolic significance of the higher TSH in obese adolescents is less clear. The objective of this study was to determine the relationship between TSH concentrations and insulin sensitivity, lipids, and adipokines in euthyroid, non-diabetic, obese adolescents. Methods: Thirty-six euthyroid, non-diabetic, obese adolescents between the ages of 12 and 18 years underwent a 75 g oral glucose tolerance test. Insulin sensitivity (S i ) and pancreatic β-cell function as assessed by disposition index (DI) were measured using the oral glucose minimal model approach. Cholesterol (total, low-density lipoprotein [LDL-C], and high-density lipoprotein [HDL-C]), triglycerides (TG), interleukin-6 (IL-6), total and high molecular weight (HMW) adiponectin, and retinol binding protein-4 (RBP4) were also determined. Associations between measures of thyroid function and S i , DI, lipids, and adipokines were computed using Pearson's correlation coefficient and multiple regression analysis. Results: The mean age of the subjects was 14.3±1.88 years, and the mean BMI was 32.5±4.65 kg/m 2 ; 97% were non-Hispanic white and 47% were male. The mean TSH was 2.7±1.2 mIU/L. Increasing serum TSH was correlated with decreasing S i (log S i ) in the entire cohort ( p =0.03), but this relationship persisted only in males ( p =0.02). The correlation between TSH and S i in males remained significant after adjusting for BMI ( p =0.02). There was no correlation between TSH and pancreatic β-cell function as assessed by DI ( p =0.48). TSH correlated positively with LDL-C ( p =0.04) and IL-6 ( p =0.03), but these associations vanished or weakened after adjusting for BMI (LDL-C p- value=0.44; IL-6 p- value=0.07). Conclusions: This study suggests a sex-specific association between TSH and insulin sensitivity in euthyroid, non-diabetic, obese adolescent males. Prospective studies are warranted to explore further this sexual dimorphism in the relationship between thyroid function and insulin sensitivity and to determine if obese adolescents with insulin resistance receiving thyroid supplements for hypothyroidism would benefit from targeting TSH levels in the lower half of normal range.
Defects in Mitochondrial Efficiency and H2O2 Emissions in Obese Women Are Restored to a Lean Phenotype With Aerobic Exercise Training
Konopka, Adam R. , Asante, Albert , Lanza, Ian R. , Man, Chiara Dalla , Amols, M., Irving, Brian A. , Robinson, Matthew M. , Johnson, Matthew L. , Amols, Mark H, Cobelli, Claudio , Nair, K. Sreekumaran , Dalla Man, Chiara , Lanza, Ian R , Konopka, Adam R

Mayo Clinic

Diabetes | January 21, 2015 | Volume: 64 | Issue: 6 | Pages: 2104-2115

10.2337/db14-1701 | PMID 25605809 Get It

The notion that mitochondria contribute to obesity-induced insulin resistance is highly debated. Therefore, we determined whether obese (BMI 33 kg/m2), insulin-resistant women with polycystic ovary syndrome had aberrant skeletal muscle mitochondrial physiology compared with lean, insulin-sensitive women (BMI 23 kg/m2). Maximal whole-body and mitochondrial oxygen consumption were not different between obese and lean women. However, obese women exhibited lower mitochondrial coupling and phosphorylation efficiency and elevated mitochondrial H2O2 (mtH2O2) emissions compared with lean women. We further evaluated the impact of 12 weeks of aerobic exercise on obesity-related impairments in insulin sensitivity and mitochondrial energetics in the fasted state and after a high-fat mixed meal. Exercise training reversed obesity-related mitochondrial derangements as evidenced by enhanced mitochondrial bioenergetics efficiency and decreased mtH2O2 production. A concomitant increase in catalase antioxidant activity and decreased DNA oxidative damage indicate improved cellular redox status and a potential mechanism contributing to improved insulin sensitivity. mtH2O2 emissions were refractory to a high-fat meal at baseline, but after exercise, mtH2O2 emissions increased after the meal, which resembles previous findings in lean individuals. We demonstrate that obese women exhibit impaired mitochondrial bioenergetics in the form of decreased efficiency and impaired mtH2O2 emissions, while exercise effectively restores mitochondrial physiology toward that of lean, insulin-sensitive individuals.